MiMedx Group Inc
NASDAQ:MDXG
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.51
9.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
MiMedx Group Inc
Wall Street
Price Targets
MDXG Price Targets Summary
MiMedx Group Inc
According to Wall Street analysts, the average 1-year price target for
MDXG
is 13.26 USD
with a low forecast of 12.12 USD and a high forecast of 14.7 USD.
MDXG Last Price Targets
MiMedx Group Inc
The latest public price target was made on Nov 15, 2024 by
Anthony Petrone
from
Mizuho Securities
,
who expects
MDXG
stock to
rise by 76%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Anthony Petrone
Mizuho Securities
|
16
USD
Upside 76% |
1 month ago
Nov 15, 2024
|
MiMedx Group (MDXG) PT Raised to $16 at Mizuho
StreetInsider
|
|
Ross Osborn
Cantor Fitzgerald
|
11
USD
Upside 21% |
5 months ago
Jul 2, 2024
|
MiMedx initiated with an Overweight at Cantor Fitzgerald
TheFly
|
|
Brooks O'Neil
Lake Street
|
12
USD
Upside 32% |
7 months ago
Apr 29, 2024
|
Proposed new LCDs likely benefit MiMedx if implemented, says Lake Street
TheFly
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MDXG's stock price target?
Price Target
13.26
USD
According to Wall Street analysts, the average 1-year price target for
MDXG
is 13.26 USD
with a low forecast of 12.12 USD and a high forecast of 14.7 USD.
What is MiMedx Group Inc's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
MiMedx Group Inc's revenue is
7%.
The projected
CAGR
for the next 4 years is
11%.
What is MiMedx Group Inc's Operating Income forecast?
Projected CAGR
20%
For the last 8 years the
compound annual growth rate for
MiMedx Group Inc's operating income is
7%.
The projected
CAGR
for the next 4 years is
20%.
What is MiMedx Group Inc's Net Income forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
MiMedx Group Inc's net income is
6%.
The projected
CAGR
for the next 3 years is
12%.
You don't have any saved screeners yet
